Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NOVACEA INC | 152,894 | reported | 15 May 2006 | tx 2+16,326−16,326 |
| RIGEL PHARMACEUTICALS INC | 35,000 | reported | 19 May 2021 | tx 24+475,000 |
| PROTEIN DESIGN LABS INC/DE | 25,000 | reported | 16 Jul 2008 | tx 16+99,750 |
| NeurogesX Inc | 10,000 | reported | 07 Jun 2012 | tx 13+245,000−40,000 |
| FACET BIOTECH CORP | 0 | reported | 21 Apr 2010 | tx 8+40,001−40,001 |
| COTHERIX INC | 0 | reported | 09 Jan 2007 | tx 6+15,150−60,600 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2021 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 25,000 | 0.00 USD | |
| 19 May 2021 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
| 15 May 2020 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 55,000 | 0.00 USD | deriv |
| 23 May 2019 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 55,000 | 0.00 USD | deriv |
| 17 May 2018 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 40,000 | 0.00 USD | deriv |
| 12 May 2017 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 40,000 | 0.00 USD | deriv |
| 11 May 2016 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 40,000 | 0.00 USD | deriv |
| 13 May 2015 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 40,000 | 0.00 USD | deriv |
| 21 May 2014 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
| 15 May 2013 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 15,000 | 0.00 USD | deriv |
| 07 Jun 2012 | GRANT_AWARD | NeurogesX Inc | 10,000 | 0.00 USD | deriv |
| 23 May 2012 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 15,000 | 0.00 USD | deriv |
| 07 Feb 2012 | GRANT_AWARD | NeurogesX Inc | 50,000 | 0.00 USD | deriv |
| 31 Jan 2012 | GRANT_AWARD | NeurogesX Inc | 20,000 | 1.01 USD | |
| 25 Oct 2011 | OTHER | NeurogesX Inc | 30,000 | 0.14 USD | deriv |
| 26 Jul 2011 | GRANT_AWARD | NeurogesX Inc | 60,000 | 1.65 USD | |
| 26 Jul 2011 | GRANT_AWARD | NeurogesX Inc | 30,000 | 0.14 USD | deriv |
| 02 Jun 2011 | GRANT_AWARD | NeurogesX Inc | 10,000 | 0.00 USD | deriv |
| 20 May 2011 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 15,000 | 0.00 USD | deriv |
| 10 Aug 2010 | PURCHASE | NeurogesX Inc | 5,000 | 6.03 USD | |
| 07 Jun 2010 | PURCHASE | NeurogesX Inc | 6,000 | 7.33 USD | first after silence |
| 08 Jun 2010 | PURCHASE | NeurogesX Inc | 4,000 | 7.18 USD | |
| 02 Jun 2010 | GRANT_AWARD | NeurogesX Inc | 10,000 | 0.00 USD | deriv |
| 28 May 2010 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 15,000 | 0.00 USD | deriv |
| 21 Apr 2010 | OTHER | FACET BIOTECH CORP | 3,334 | 27.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 07 Jun 2010.